Skip to content
10-Q/A

Quarterly Report

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

0001144204-12-067374

← back to feed
Filed
Dec 11, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Dec 5, 2012 35.13M sh
Shares Diluted Q3 2012 · Sep 30, 2012 35.13M sh
Shares Diluted Q3 2012 · Sep 30, 2012 34.81M sh
Shares Diluted Q3 2012 · Sep 30, 2011 34.01M sh
Shares Diluted Q3 2012 · Sep 30, 2011 32.4M sh
Capex Q3 2012 · Sep 30, 2012 $506
Capex Q3 2012 · Sep 30, 2011 $14.79M
Operating Cash Flow Q3 2012 · Sep 30, 2012 $15.25M
Operating Cash Flow Q3 2012 · Sep 30, 2011 $11.93M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $85.52M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $70.78M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $51.48M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $50.36M
Stockholders Equity Q3 2012 · Sep 30, 2012 $124.96M
Stockholders Equity Q3 2012 · Dec 31, 2011 $112.1M
Stockholders Equity Q3 2012 · Dec 31, 2010 $66.93M
Current Liabilities Q3 2012 · Sep 30, 2012 $2.47M
Current Liabilities Q3 2012 · Dec 31, 2011 $7.56M
Current Assets Q3 2012 · Sep 30, 2012 $91.19M
Current Assets Q3 2012 · Dec 31, 2011 $81.85M
Total Assets Q3 2012 · Sep 30, 2012 $130.8M
Total Assets Q3 2012 · Dec 31, 2011 $123.19M
Eps Diluted Q3 2012 · Sep 30, 2012 $0.10
Eps Diluted Q3 2012 · Sep 30, 2012 $0.32
Eps Diluted Q3 2012 · Sep 30, 2011 $0.03
Eps Diluted Q3 2012 · Sep 30, 2011 $0.50
Eps Basic Q3 2012 · Sep 30, 2012 $0.10
Eps Basic Q3 2012 · Sep 30, 2012 $0.32
Eps Basic Q3 2012 · Sep 30, 2011 $0.03
Eps Basic Q3 2012 · Sep 30, 2011 $0.50
Sga Expense Q3 2012 · Sep 30, 2012 $548.14K
Sga Expense Q3 2012 · Sep 30, 2012 $4.03M
Sga Expense Q3 2012 · Sep 30, 2011 $6.57M
Sga Expense Q3 2012 · Sep 30, 2011 $11.14M
Net Income Q3 2012 · Sep 30, 2012 $3.51M
Net Income Q3 2012 · Sep 30, 2012 $11.08M
Net Income Q3 2012 · Dec 31, 2011 $29.63M
Net Income Q3 2012 · Sep 30, 2011 $1.18M
Net Income Q3 2012 · Sep 30, 2011 $16.23M
Operating Income Q3 2012 · Sep 30, 2012 $4.6M
Operating Income Q3 2012 · Sep 30, 2012 $15.35M
Operating Income Q3 2012 · Sep 30, 2011 $3.45M
Operating Income Q3 2012 · Sep 30, 2011 $24.17M
Gross Profit Q3 2012 · Sep 30, 2012 $5.76M
Gross Profit Q3 2012 · Sep 30, 2012 $21.25M
Gross Profit Q3 2012 · Sep 30, 2011 $10.85M
Gross Profit Q3 2012 · Sep 30, 2011 $38.72M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $5.38M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $18.54M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $8.56M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $25.9M
Revenue Q3 2012 · Sep 30, 2012 $11.14M
Revenue Q3 2012 · Sep 30, 2012 $39.79M
Revenue Q3 2012 · Sep 30, 2011 $19.4M
Revenue Q3 2012 · Sep 30, 2011 $64.63M
Rd Expense Q3 2012 · Sep 30, 2011 $12.64K
Rd Expense Q3 2012 · Sep 30, 2011 $12.64K